Clinical utility of 18F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in prostate cancer patients and comparing with18 F-FDG PET/CT and conventional imaging modality

被引：0
|
作者：
Phulsunga, R. K., Jr. [1 ]
Parghane, R., Sr. [1 ]
Shukla, J. [1 ]
Mittal, B. [1 ]
机构：
[1] PGIMER, Chandigarh, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P116
引用
收藏
页码：S396 / S397
页数：2
相关论文
共 50 条
  • [21] Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors
    Matsumoto, Takashi
    Okabe, Hirohisa
    Yamashita, Yo-ichi
    Yusa, Toshihiko
    Itoyama, Rumi
    Nakao, Yosuke
    Yamao, Takanobu
    Umzaki, Naoki
    Tsukamoto, Masayo
    Kitano, Yuki
    Miyata, Tatsunori
    Arima, Kota
    Nitta, Hidetoshi
    Hayashi, Hiromitsu
    Imai, Katsunori
    Chikamoto, Akira
    Baba, Hideo
    SURGERY TODAY, 2019, 49 (01) : 21 - 26
  • [22] Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors
    Takashi Matsumoto
    Hirohisa Okabe
    Yo-ichi Yamashita
    Toshihiko Yusa
    Rumi Itoyama
    Yosuke Nakao
    Takanobu Yamao
    Naoki Umzaki
    Masayo Tsukamoto
    Yuki Kitano
    Tatsunori Miyata
    Kota Arima
    Hidetoshi Nitta
    Hiromitsu Hayashi
    Katsunori Imai
    Akira Chikamoto
    Hideo Baba
    Surgery Today, 2019, 49 : 21 - 26
  • [23] Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer
    Goh, Vicky
    Cook, Gary
    BJU INTERNATIONAL, 2013, 112 (06) : 709 - 709
  • [24] Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer
    Kjolhede, Henrik
    Ahlgren, Goran
    Almquist, Helen
    Liedberg, Fredrik
    Lyttkens, Kerstin
    Ohlsson, Tomas
    Bratt, Ola
    BJU INTERNATIONAL, 2012, 110 (10) : 1501 - 1506
  • [25] Impact of 18F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle
    Mertens, Laura S.
    Fioole-Bruining, Annemarie
    Vegt, Erik
    Vogel, Wouter V.
    van Rhijn, Bas W.
    Horenblas, Simon
    BJU INTERNATIONAL, 2013, 112 (06) : 729 - 734
  • [26] The use of 18F-fluorothymidine and 18F-fluorocholine in imaging with positron emission tomography
    Skoura, Evangelia
    Datseris, Ioannis E.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2010, 13 (01): : 88 - 90
  • [27] Supraclavicular metastasis in prostate cancer detected with 18F-Fluorocholine PET/CT
    Nunez Miller, R.
    Viera, J. C.
    Jover Diaz, R.
    Rojo Sebastian, A.
    Pozo, M. A.
    Alfonso Alfonso, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2012, 31 (01): : 44 - 46
  • [28] 18F-Fluorocholine, 18F-FDG, and 18F-Fluoroethyl Tyrosine PET/CT in Parathyroid Cancer
    Hatzl, Margit
    Roeper-Kelmayr, Julia C.
    Fellner, Franz A.
    Gabriel, Michael
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (06) : 448 - 450
  • [29] The Role of 11C-Choline and 18F-Fluorocholine Positron Emission Tomography (PET) and PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis
    Umbehr, Martin H.
    Muentener, Michael
    Hany, Thomas
    Sulser, Tullio
    Bachmann, Lucas M.
    EUROPEAN UROLOGY, 2013, 64 (01) : 106 - 117
  • [30] The use of [18F]-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) for predicting recurrence in cervical cancer patients
    Brunette, L.
    Mehta, A.
    Lieber, D.
    Bonyadlou, S.
    Lin, Y.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 389 - 389
12345